Cargando…
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species
Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly immunosuppressive in both animal disease models and human clinical trials. We have reported that the key molecule mediating immunosuppression by MSCs is species dependent: indoleamine 2,3-dioxygenase (IDO) in human and inducible...
Autores principales: | Su, J, Chen, X, Huang, Y, Li, W, Li, J, Cao, K, Cao, G, Zhang, L, Li, F, Roberts, A I, Kang, H, Yu, P, Ren, G, Ji, W, Wang, Y, Shi, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921585/ https://www.ncbi.nlm.nih.gov/pubmed/24162664 http://dx.doi.org/10.1038/cdd.2013.149 |
Ejemplares similares
-
Interplay between IDO1 and iNOS in human retinal pigment epithelial cells
por: Spekker-Bosker, Katrin, et al.
Publicado: (2019) -
eNOS/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia
por: Du, L, et al.
Publicado: (2017) -
Nanoparticle encapsulated CQ/TAM combination harmonizes with MSCs in arresting progression of severity in AP mice through iNOS (IDO) signaling
por: Liu, Huimin, et al.
Publicado: (2022) -
Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells
por: Wang, Guan, et al.
Publicado: (2017) -
Obesity-Induced Coronary Microvascular Disease Is Prevented by iNOS Deletion and Reversed by iNOS Inhibition
por: Shah, Soham A., et al.
Publicado: (2023)